333 related articles for article (PubMed ID: 28663100)
1. A New AAV10-U7-Mediated Gene Therapy Prolongs Survival and Restores Function in an ALS Mouse Model.
Biferi MG; Cohen-Tannoudji M; Cappelletto A; Giroux B; Roda M; Astord S; Marais T; Bos C; Voit T; Ferry A; Barkats M
Mol Ther; 2017 Sep; 25(9):2038-2052. PubMed ID: 28663100
[TBL] [Abstract][Full Text] [Related]
2. AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS.
Leyton-Jaimes MF; Kahn J; Israelson A
Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14755-14760. PubMed ID: 31262807
[TBL] [Abstract][Full Text] [Related]
3. Treatment of a Mouse Model of ALS by In Vivo Base Editing.
Lim CKW; Gapinske M; Brooks AK; Woods WS; Powell JE; Zeballos C MA; Winter J; Perez-Pinera P; Gaj T
Mol Ther; 2020 Apr; 28(4):1177-1189. PubMed ID: 31991108
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model.
Stoica L; Todeasa SH; Cabrera GT; Salameh JS; ElMallah MK; Mueller C; Brown RH; Sena-Esteves M
Ann Neurol; 2016 Apr; 79(4):687-700. PubMed ID: 26891182
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic rAAVrh10 Mediated SOD1 Silencing in Adult SOD1(G93A) Mice and Nonhuman Primates.
Borel F; Gernoux G; Cardozo B; Metterville JP; Toro Cabrera GC; Song L; Su Q; Gao GP; Elmallah MK; Brown RH; Mueller C
Hum Gene Ther; 2016 Jan; 27(1):19-31. PubMed ID: 26710998
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
[TBL] [Abstract][Full Text] [Related]
7. Subpial delivery of adeno-associated virus 9-synapsin-caveolin-1 (
Wang S; Ichinomiya T; Savchenko P; Wang D; Sawada A; Li X; Duong T; Li W; Bonds JA; Kim EJ; Miyanohara A; Roth DM; Patel HH; Patel PM; Tadokoro T; Marsala M; Head BP
Theranostics; 2022; 12(12):5389-5403. PubMed ID: 35910808
[TBL] [Abstract][Full Text] [Related]
8. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
9. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
10. Intralingual Administration of AAVrh10-miR
Lind LA; Andel EM; McCall AL; Dhindsa JS; Johnson KA; Stricklin OE; Mueller C; ElMallah MK; Lever TE; Nichols NL
Hum Gene Ther; 2020 Aug; 31(15-16):828-838. PubMed ID: 32498636
[TBL] [Abstract][Full Text] [Related]
11. ALS-linked SOD1 mutations impair mitochondrial-derived vesicle formation and accelerate aging.
Guo Y; Guan T; Yu Q; Sanghai N; Shafiq K; Li M; Jiao X; Na D; Zhang G; Kong J
Redox Biol; 2024 Feb; 69():102972. PubMed ID: 38056310
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS.
Foust KD; Salazar DL; Likhite S; Ferraiuolo L; Ditsworth D; Ilieva H; Meyer K; Schmelzer L; Braun L; Cleveland DW; Kaspar BK
Mol Ther; 2013 Dec; 21(12):2148-59. PubMed ID: 24008656
[TBL] [Abstract][Full Text] [Related]
13. Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS).
Abati E; Bresolin N; Comi G; Corti S
Expert Opin Ther Targets; 2020 Apr; 24(4):295-310. PubMed ID: 32125907
[No Abstract] [Full Text] [Related]
14. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
[TBL] [Abstract][Full Text] [Related]
15. In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model.
Chen YA; Kankel MW; Hana S; Lau SK; Zavodszky MI; McKissick O; Mastrangelo N; Dion J; Wang B; Ferretti D; Koske D; Lehman S; Koszka K; McLaughlin H; Liu M; Marshall E; Fabian AJ; Cullen P; Marsh G; Hamann S; Craft M; Sebalusky J; Arnold HM; Driscoll R; Sheehy A; Luo Y; Manca S; Carlile T; Sun C; Sigrist K; McCampbell A; Henderson CE; Lo SC
Gene Ther; 2023 May; 30(5):443-454. PubMed ID: 36450833
[TBL] [Abstract][Full Text] [Related]
16. In vivo genome editing improves motor function and extends survival in a mouse model of ALS.
Gaj T; Ojala DS; Ekman FK; Byrne LC; Limsirichai P; Schaffer DV
Sci Adv; 2017 Dec; 3(12):eaar3952. PubMed ID: 29279867
[TBL] [Abstract][Full Text] [Related]
17. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.
Azzouz M; Ralph GS; Storkebaum E; Walmsley LE; Mitrophanous KA; Kingsman SM; Carmeliet P; Mazarakis ND
Nature; 2004 May; 429(6990):413-7. PubMed ID: 15164063
[TBL] [Abstract][Full Text] [Related]
18. Silencing strategies for therapy of SOD1-mediated ALS.
van Zundert B; Brown RH
Neurosci Lett; 2017 Jan; 636():32-39. PubMed ID: 27507699
[TBL] [Abstract][Full Text] [Related]
19. Molecular dissection of ALS-associated toxicity of SOD1 in transgenic mice using an exon-fusion approach.
Deng HX; Jiang H; Fu R; Zhai H; Shi Y; Liu E; Hirano M; Dal Canto MC; Siddique T
Hum Mol Genet; 2008 Aug; 17(15):2310-9. PubMed ID: 18424447
[TBL] [Abstract][Full Text] [Related]
20. The alteration of serine transporter activity in a cell line model of amyotrophic lateral sclerosis (ALS).
Lee NY; Kim Y; Ryu H; Kang YS
Biochem Biophys Res Commun; 2017 Jan; 483(1):135-141. PubMed ID: 28043791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
